Inserm Phage Therapy Booster Programme: call for letters of intent to build a national phage therapy consortium

Inserm's Phage Therapy booster programme, led by its Health technologies and Immunology, inflammation, infectiology and microbiology institutes, will fund a single three-year consortium of 10-12 participants (individual researchers or teams) working on phage biotechnology and bioproduction, preclinical frameworks and the societal impact of phage therapy. The call for letters of intent opened on 10 July 2026 and closed on 18 September 2026 at 5:00 PM; the programme kick-off meeting is scheduled for 28 January 2027.